Access in all areas? A roundup of developments in market access and health technology assessment: part 6.

IF 1.9 4区医学 Q3 HEALTH CARE SCIENCES & SERVICES

Journal of comparative effectiveness research Pub Date : 2025-03-01 Epub Date: 2025-01-10 DOI:10.57264/cer-2024-0239

Annie Jullien Pannelay, Ramiro E Gilardino, Sreeram V Ramagopalan

引用次数: 0

Abstract

In this update, we discuss an article covering the implementation challenges of the upcoming European Union Health Technology Assessment regulation, particularly focusing on the complexity of population, intervention, comparator and outcomes requirements across member states; a user guide to applying generalized cost-effectiveness analysis for broader value assessment and finally highlight an ongoing debate surrounding National Institute for Health and Care Excellence's severity modifier implementation.

查看原文本刊更多论文

所有地区都能通行吗？市场准入和卫生技术评估方面的发展综述：第6部分。

在本次更新中，我们讨论了一篇文章，该文章涵盖了即将出台的欧盟卫生技术评估法规的实施挑战，特别关注各成员国人口、干预、比较和结果要求的复杂性；将广义成本效益分析应用于更广泛的价值评估的用户指南，最后强调围绕国家健康和护理卓越研究所的严重程度修改器实施的持续辩论。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of comparative effectiveness research HEALTH CARE SCIENCES & SERVICES-

CiteScore

3.50

自引率

9.50%

发文量

121

期刊介绍： Journal of Comparative Effectiveness Research provides a rapid-publication platform for debate, and for the presentation of new findings and research methodologies. Through rigorous evaluation and comprehensive coverage, the Journal of Comparative Effectiveness Research provides stakeholders (including patients, clinicians, healthcare purchasers, and health policy makers) with the key data and opinions to make informed and specific decisions on clinical practice.